Bernard Horowitz
Corporate Officer/Principal bei Horowitz Consultants LLC
Profil
Bernard Horowitz has been a Director of OMRIX Biopharmaceuticals, Inc. since February 2006.
Dr. Horowitz is a Director of Protein Therapeutics, Inc. Since January 2000, he has been a Principal of Horowitz Consultants LLC.
From 1995 to 1999, Dr. Horowitz served as Chief Scientific Officer, Executive Vice President and a Director of V.I.
Technologies, Inc. He served as a Scientific Consultant to the National Institutes of Health, the Food and Drug Administration, the National Hemophilia Foundation, the International Association of Biological Standardization and the World Health Organization.
He received a BS degree in Biology from the University of Chicago and a PhD in Biochemistry from Cornell University Medical College.
Aktive Positionen von Bernard Horowitz
| Unternehmen | Position | Beginn |
|---|---|---|
| Horowitz Consultants LLC | Corporate Officer/Principal | 01.01.2000 |
Ehemalige bekannte Positionen von Bernard Horowitz
| Unternehmen | Position | Ende |
|---|---|---|
OMRIX Biopharmaceuticals, Inc.
 OMRIX Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OMRIX Biopharmaceuticals, Inc. specializes in the manufacture and development of biosurgical and passive immunotherapy products. Its product range encompasses hemostatic, surgical, and immunotherapy solutions. The firm offers solutions for bleeding control, surgical operations, and biodefense applications. The company was founded by Robert Taub in 1995 and is headquartered in Somerville, NJ. | Direktor/Vorstandsmitglied | 30.12.2008 |
Biogentis, Inc.
 Biogentis, Inc. Pharmaceuticals: MajorHealth Technology Biogentis, Inc. is a biopharmaceutical company, which designs and develops healthcare solutions in the field of advanced wound care and regenerative medicines. The company provides three technology platforms: Dermalink, a fibronectin-based product for chronic wound healing, CyanoStrip, a wound closure system and a self-assembly tissue engineering technology. It is located in Montréal, Canada | Direktor/Vorstandsmitglied | 27.02.2008 |
V.I. Technologies, Inc.
 V.I. Technologies, Inc. BiotechnologyHealth Technology Vitex is a Delaware Corporation incorporated in 1995. Vitex’s scientific and clinical programs originated in anti-infective technologies designed to prevent the spread of infectious disease by blood transfusions. In March of 2005, Vitex merged with Panacos Pharmaceuticals, a private company developing HIV therapeutics with novel mechanisms of action. The merger with Panacos immediately expanded the Vitex pipeline into novel, high value therapeutics. The Panacos team that joined Vitex is recognized for fundamental contributions to HIV biology and drug development | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1999 |
Protein Therapeutics, Inc.
 Protein Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Protein Therapeutics, Inc. developed pharmaceuticals. The company was headquartered in Tucson, AZ. | Direktor/Vorstandsmitglied | - |
Ausbildung von Bernard Horowitz
| The University of Chicago | Undergraduate Degree |
| Cornell University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
V.I. Technologies, Inc.
V.I. Technologies, Inc. BiotechnologyHealth Technology Vitex is a Delaware Corporation incorporated in 1995. Vitex’s scientific and clinical programs originated in anti-infective technologies designed to prevent the spread of infectious disease by blood transfusions. In March of 2005, Vitex merged with Panacos Pharmaceuticals, a private company developing HIV therapeutics with novel mechanisms of action. The merger with Panacos immediately expanded the Vitex pipeline into novel, high value therapeutics. The Panacos team that joined Vitex is recognized for fundamental contributions to HIV biology and drug development | Health Technology |
OMRIX Biopharmaceuticals, Inc.
OMRIX Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OMRIX Biopharmaceuticals, Inc. specializes in the manufacture and development of biosurgical and passive immunotherapy products. Its product range encompasses hemostatic, surgical, and immunotherapy solutions. The firm offers solutions for bleeding control, surgical operations, and biodefense applications. The company was founded by Robert Taub in 1995 and is headquartered in Somerville, NJ. | Health Technology |
Protein Therapeutics, Inc.
Protein Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Protein Therapeutics, Inc. developed pharmaceuticals. The company was headquartered in Tucson, AZ. | Health Technology |
Biogentis, Inc.
Biogentis, Inc. Pharmaceuticals: MajorHealth Technology Biogentis, Inc. is a biopharmaceutical company, which designs and develops healthcare solutions in the field of advanced wound care and regenerative medicines. The company provides three technology platforms: Dermalink, a fibronectin-based product for chronic wound healing, CyanoStrip, a wound closure system and a self-assembly tissue engineering technology. It is located in Montréal, Canada | Health Technology |
| Horowitz Consultants LLC |
